8,000 séquels por paquete: la nueva esperanza para pacientes con esquizofrenia está fuera de su alcance
Un medicamento con un nuevo mecanismo de acción ofrece una opción de tratamiento adicional para quienes padecen la enfermedad, pero su precio deja a muchos esperando su inclusión en la canasta de salud. Madre de…
Valoración
A new schizophrenia drug with a novel mechanism of action has entered the Israeli market at 8,000 shekels per pack, placing it out of reach for most patients. The price tag means access depends entirely on inclusion in the national health basket, a bureaucratic process that moves slowly. One patient advocate states plainly that families simply cannot buy it if it stays outside the basket. The immediate question is whether the Health Ministry will prioritize this drug in the next basket update, and how many patients will wait in the meantime.